We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Wins Court Order Prohibiting GSK From Providing Generic Paxil CR to Competitor
Mylan Wins Court Order Prohibiting GSK From Providing Generic Paxil CR to Competitor
Mylan has further cemented its win in a breach-of-contract lawsuit against GlaxoSmithKline with a court order prohibiting GSK from providing an authorized generic version of the antidepressant Paxil to Mylan’s competitor Apotex.